Free Trial

Pelthos Therapeutics (PTHS) Earnings Date, Estimates & Call Transcripts

Pelthos Therapeutics logo
$25.45 +0.63 (+2.54%)
As of 05/5/2026 04:10 PM Eastern

Pelthos Therapeutics Earnings Summary

Pelthos Therapeutics issued Q4 2025 earnings on March 19, 2026, reporting an EPS of -$6.87. Quarterly revenue was reported to be $9.39 million. With a trailing EPS of $0.00, Pelthos Therapeutics' earnings are expected to grow next year, from ($11.35) to ($1.15) per share.

Actual Revenue
(Mar. 19)
$9.39M

Q4 2025 Earnings Resources

Get Pelthos Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pelthos Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Pelthos Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$4.49-$4.49-$4.49
Q2 20261-$3.48-$3.48-$3.48
Q3 20261-$2.29-$2.29-$2.29
Q4 20261-$2.60-$2.60-$2.60

Pelthos Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/19/2026Q4 2025--$6.87--$6.87-$9.39M

Data powered by Fiscal.ai.

Pelthos Therapeutics Earnings - Frequently Asked Questions

Pelthos Therapeutics (NYSEAMERICAN:PTHS) last announced its quarterly earning data on Thursday, March 19, 2026. Learn more on PTHS's earnings history.

The conference call for Pelthos Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Pelthos Therapeutics' latest earnings report can be read online.
Read Transcript

Pelthos Therapeutics (NYSEAMERICAN:PTHS) has a recorded annual revenue of $16.80 million.

Pelthos Therapeutics (NYSEAMERICAN:PTHS) has a recorded net income of -$43.32 million. PTHS has generated $0.00 earnings per share over the last four quarters.

Pelthos Therapeutics' earnings are expected to grow from ($11.35) per share to ($1.15) per share in the next year.


This page (NYSEAMERICAN:PTHS) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners